-AP New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations. The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine. If Pfizer is...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...

-Scroll.in The government is yet to frame policies on how to tackle severe acute malnutrition but non-profits have started experimenting with community-based models. Nurses call him "the boy who lived." Severely dehydrated, unconscious and weighing no more than two kilos, lighter than a healthy new born, one-year-old Subhash was brought to the Darbhanga Medical College in Bihar in February. Admitted to Malnutrition Intensive Care Unit, he was administered glucose, therapeutic milk...

-The Telegraph New Delhi: Health experts today criticised a government delay in implementing a proposed daily drug therapy for tuberculosis patients, meant to reduce the risk of relapse after completion of treatment. Although the health ministry had itself last year released TB treatment standards emphasising a move towards daily therapy, virtually all patients treated under the government TB control programme receive thrice-a-week therapy, which carries a higher risk of relapse. A consortium of...